Care of non-ST-segment elevation patients: Insights from the crusade national quality improvement initiative - 26/08/11

Doi : 10.1016/j.ahj.2004.09.013

E.Magnus Ohman, MD ^a,^⁎ , Matthew T. Roe, MD ^b, Sidney C. Smith, MD ^a, Ralph G. Brindis, MD ^c, Robert H. Christenson, PhD ^d, Robert A. Harrington, MD ^b, W.Brian Gibler, MD ^e, Eric D. Peterson, MD ^b
CRUSADE Investigators
^a Division of Cardiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
^b Duke Clinical Research Institute/Duke University Medical Center, Durham, NC, USA
^c San Francisco Kaiser Hospital, Division of Cardiology, San Francisco, Calif, USA
^d Department of Pathology, University of Maryland, Baltimore, Md, USA
^e Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio, USA

^*Reprint requests: E. Magnus Ohman, MD, University of North Carolina at Chapel Hill, CB #7075, Bioinformatics Bldg, Room 4146, 130 Mason Farm Road, Chapel Hill, NC 27599, USA.

Abstract

Acute coronary syndromes (ACS), including non-ST-segment elevation (NSTE) ACS, represent a significant source of morbidity and mortality in the United States. To address this widespread, serious health problem, the American College of Cardiology and the American Heart Association (ACC/AHA) published guidelines for the treatment of NSTE ACS, which include unstable angina (UA) and NSTE myocardial infarction (NSTEMI). These ACC/AHA guidelines are intended to help physicians make appropriate decisions when diagnosing and treating patients with NSTE ACS.

Le texte complet de cet article est disponible en PDF.